Peter Olinga

Bekijk Scopus-profiel

Telefoon+31 50 363 8373, +31 50 363 2500
E-mailP.Olingarugnl

A Deusinglaan1, Gebouw 3213, ruimte 0205
9713 AV Groningen
Netherlands

Als u wijzigingen in Pure hebt gemaakt, zullen deze hier binnenkort zichtbaar zijn.

Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment
Woerdenbag, H. J., Olinga, P., Kok, E. A., Brugman, D. A. P., van Ark, U. F., Ramcharan, A. S., Lebbink, P. W., Hoogwater, F. J. H., Knapen, D. G., de Groot, D. J. A. & Nijkamp, M. W., 1-apr.-2023, In: Cancers. 15, 7, 2119.
Onderzoeksoutput: Review article › peer review

Open Access
Bestand

3 Downloads (Pure)
Restoration of Bile Duct Injury of Donor Livers During Ex Situ Normothermic Machine Perfusion
de Jong, I. E. M., Bodewes, S. B., van Leeuwen, O. B., Oosterhuis, D., Lantinga, V. A., Thorne, A. M., Lascaris, B., van den Heuvel, M. C., Wells, R. G., Olinga, P., de Meijer, V. E. & Porte, R. J., 1-feb.-2023, (E-pub ahead of print) In: Transplantation.
Onderzoeksoutput › Academic › peer review

Open Access
Bestand

8 Downloads (Pure)
Development of an ex vivo model for non-alcoholic fatty liver disease using precision-cut liver slices
Li, M., de Meijer, V., Olinga, P., Nagelkerke, A. & Geng, Y., jul.-2022, In: Journal of Hepatology. 77, blz. S711-S711 1 blz.
Onderzoeksoutput › Academic
Distinct responses between healthy and cirrhotic human livers upon lipopolysaccharide challenge: possible implications for acute-on-chronic liver failure
Suriguga, S., Li, M., Luangmonkong, T., Boersema, M., de Jong, K. P., Oosterhuis, D., Gorter, A. R., Beljaars, L. & Olinga, P., 1-aug.-2022, In: American journal of physiology. Gastrointestinal and liver physiology. 323, 2, blz. G114-G125 12 blz.
Onderzoeksoutput › Academic › peer review

Open Access
Bestand

31 Downloads (Pure)
Evaluation of the antifibrotic effects of naringenin, asiatic acid and icariin by using precision-cut liver slices of mouse and human
Luo, K., Geng, Y., de Meijer, V., Oosterhuis, D. & Olinga, P., jul.-2022, In: Journal of Hepatology. 77, blz. S484-S484 1 blz.
Onderzoeksoutput › Academic

2 Academic presentation
1 Attending an event

Human ex vivo models for liver disease
Peter Olinga (Keynote speaker)
dec.-2018
Activiteit: Academic presentation › Academic
Drug targeting meets liver fibrosis
Peter Olinga (Invited speaker)
sep.-2018
Activiteit: Academic presentation › Academic
Pharmacy Day
Peter Olinga (Attendee)
9-jun.-2015
Activiteit: Attending an event › Academic

Proefdiervrij moet betrouwbaardere en waardevollere wetenschap opleveren
Henri Leuvenink & Peter Olinga
19/04/2019
1 item van Media-aandacht
Pers / media: Activiteiten met een maatschappelijk belang › Professional

Peter Olinga

Netwerk

Duik in details

Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment

Restoration of Bile Duct Injury of Donor Livers During Ex Situ Normothermic Machine Perfusion

Development of an ex vivo model for non-alcoholic fatty liver disease using precision-cut liver slices

Distinct responses between healthy and cirrhotic human livers upon lipopolysaccharide challenge: possible implications for acute-on-chronic liver failure

Evaluation of the antifibrotic effects of naringenin, asiatic acid and icariin by using precision-cut liver slices of mouse and human

Human ex vivo models for liver disease

Drug targeting meets liver fibrosis

Pharmacy Day

Proefdiervrij moet betrouwbaardere en waardevollere wetenschap opleveren

Peter Olinga

Netwerk

Onderzoeksoutput

Activiteiten

Knipsels